FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma
Ghali, Ramy R; Shaheen, Sara M; elhamamsy, manal; Saad, Amr Shafik; Salem, Ahmed M;
Abstract
FAS-670 A>G (rs1800682) and FASL-844 C>T (rs763110) polymorphisms have been previously correlated with clinical outcome of non-small cell lung cancer (NSCLC) and breast and bladder cancers. We investigated the influence of these polymorphisms on clinical outcome of malignant pleural mesothelioma (MPM) patients.
Other data
| Title | FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma | Authors | Ghali, Ramy R; Shaheen, Sara M; elhamamsy, manal ; Saad, Amr Shafik; Salem, Ahmed M | Keywords | FAS; FAS ligand; genotyping; mesothelioma; platinum; survival | Issue Date | 2016 | Journal | OncoTargets and therapy | ISSN | 1178-6930 | DOI | 10.2147/OTT.S115631 | PubMed ID | 27853379 | Scopus ID | 2-s2.0-84995630364 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.